Investor Relations Home

Printer Friendly Version Print Page  |E-mail this page E-mail Page  |E-mail Alerts E-mail Alerts  |View contacts IR Contacts

Corporate Profile

About Bio-Reference Laboratories, Inc.
BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world.

Read More »

Recent NewsMore »
DateTitle 
07/02/15OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned AcquisitionPrinter Friendly Version
06/08/15Bio-Reference Laboratories, Inc. Reports Solid Revenues and Earnings for Q2FY15Printer Friendly Version
06/08/15OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss MergerPrinter Friendly Version
Stock Quote
BRLI (common stock)
ExchangeNASDAQ (US Dollar)
Price$44.37
Change (%) - 0.12 (0.27%)
Volume490,730
Data as of 07/31/15 4:00 p.m. ET
Refresh quote
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Bio-Reference Laboratories, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Data provided by Nasdaq. Minimum 15 minutes delayed.